Coeptis Therapeutics Holdings, Inc.
COEP
$9.67
-$0.08-0.82%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.83M | -3.04M | -3.00M | -3.76M | -6.35M |
| Total Depreciation and Amortization | 278.20K | 250.20K | 250.20K | 250.30K | 280.50K |
| Total Amortization of Deferred Charges | 0.00 | 0.00 | 150.00K | -- | -- |
| Total Other Non-Cash Items | -203.10K | 1.40M | 611.90K | 904.10K | 3.87M |
| Change in Net Operating Assets | -138.80K | -29.00K | 86.90K | 907.30K | 240.80K |
| Cash from Operations | -1.89M | -1.42M | -1.90M | -1.69M | -1.96M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | -100.00K | -- | 350.00K |
| Cash from Investing | 0.00 | 0.00 | -100.00K | -- | 350.00K |
| Total Debt Issued | 0.00 | 500.00K | 1.35M | 150.00K | -2.89M |
| Total Debt Repaid | 0.00 | -300.00K | -287.50K | -350.00K | -875.00K |
| Issuance of Common Stock | -- | -- | 500.00K | 1.75M | 3.54M |
| Repurchase of Common Stock | -50.00K | -450.00K | -- | -- | -- |
| Issuance of Preferred Stock | 1.53M | 1.69M | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 500.00K | -- | 200.00K | -- |
| Cash from Financing | 1.48M | 1.94M | 1.56M | 1.75M | -224.90K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | -- | -- | -- | -- |
| Net Change in Cash | -417.60K | 525.80K | -439.90K | 57.60K | -1.83M |
